(19)
(11) EP 2 192 918 A1

(12)

(43) Date of publication:
09.06.2010 Bulletin 2010/23

(21) Application number: 08798605.5

(22) Date of filing: 25.08.2008
(51) International Patent Classification (IPC): 
A61K 39/21(2006.01)
C07K 14/16(2006.01)
(86) International application number:
PCT/US2008/074179
(87) International publication number:
WO 2009/029569 (05.03.2009 Gazette 2009/10)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 24.08.2007 US 966048 P

(71) Applicant: Novartis AG
4056 Basel (CH)

(72) Inventors:
  • BARNETT, Susan W.
    Emeryville, California 94662-8907 (US)
  • LIAN, Ying
    Emeryville, California 94662-8907 (US)
  • SHARMA, Victoria
    Emeryville, California 94662-8907 (US)
  • SRIVASTAVA, Indresh K.
    Emeryville, California 94662-8907 (US)

(74) Representative: Marshall, Cameron John 
Carpmaels & Ransford 43-45 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) HIV ENV PROTEINS WITH MODIFICATIONS IN THE V3 LOOP